Latest PARTICIPATE Geographic news presence and 2017 highlights Local proximity (a) €6,776M Since the production of industrial gases is a local activity, the Group has gradually established a presence EUROPE in all regions across the globe and now operates • Opening of the first remote operation and optimization in 80 countries. Each region has experienced their center for ir iuide production units in rance own growth dynamics. This geographic and industrial • Long-term contracts with rcelor ittal in rance and diversity contributes to the Group’s resilience. in enelux to supply oxygen, nitrogen and argon • “Chronic Care Connect™” e-health solution to remotely support patients suffering from certain chronic diseases at home, in rance and in Spain AMERICAS EUROPE MIDDLE EAST ASIA-PACIFIC In North America, The Group’s leading AND AFRICA Rapid development the chemicals and energy business in Europe, The Group’s products in China and South sectors are the growth Healthcare offers and services support East Asia has created (a) (a) drivers. In the United States, bright prospects infrastructure a growing need for €8,150M €4,081M the leading industrial gas with the development development in the Middle infrastructure and energy, market worldwide, Airgas’s of home healthcare. East, especially in the with a particular focus AMERICAS ASIA-PACIFIC integration gave a new Large Industries is energy and petrochemical on energy efficiency. • Synergies related to irgas ahead • Long-term contracts with three dimension to Industrial supported by major sectors. Air Liquide Growth has been steady • major Chinese optical fiber of plan for ­€‚ƒ Merchant, which serves European industrial sets itself apart here in Large Industries and • Long-term contract with „emex manufacturers to supply many sectors, such as basins in which by implementing major in Industrial Merchant • hydrogen, nitrogen, oxygen, in exico to supply hydrogen to be used to produce cleaner fuels helium, argon and carbon dioxide automotive, food and Air Liquide has developed industrial projects, such and is based on local • Acquisition of Sogo Sangyo pharmaceuticals. In South a vast pipeline network– as in Saudi Arabia (largest consumption. Kabushiki Kaisha in Japan, America, Air Liquide a competitive advantage hydrogen production site The region, and notably a major player in the home (a) €635M healthcare and medical contributes to the for the Group. Industrial in the world), and in South China, has been driven gases sectors development of Merchant benefits Africa (construction and by the semiconductors • Long-term contracts with infrastructures that require in particular from operation of the largest sector, holding a large MIDDLE EAST leading electronic component manufacturers in China, Japan large quantities of industrial momentum in the food, oxygen production unit portion of the Group’s AND AFRICA and Singapore to supply gases. Healthcare is also pharmaceutical for Sasol, a long-standing Electronics business. • Long-term contract with Orpic ultra-pure carrier gases supported by high demand, and research and partner). Throughout the Growing in the region, in Oman to supply nitrogen to a plastic manufacturing site particularly in Brazil technology sectors. entire region, Industrial Healthcare is dynamic, • Commissioning of the ord’s and in Argentina, and by Lastly, environmental Merchant has benefited especially in Japan. argest oygen production unit (a) 2017 revenue in million euros. acquisitions like in Canada protection solutions– from a strong industrial Air Liquide is also starting in South frica for Sasol, an international integrated energy The geographic analysis of 2017 performance for the past several years, such as clean transport, growth, and Healthcare to position itself in the and chemicals company can be found in the management report and in Colombia for instance–are growth has benefited from growth up and coming Chinese published on February 15 201 and included in the 2017 eference ocument. more recently. drivers. in home healthcare. healthcare market. 13

2018 Shareholder's Guide - Page 13 2018 Shareholder's Guide Page 12 Page 14